scispace - formally typeset
K

Kairat Davletov

Researcher at Al-Farabi University

Publications -  11
Citations -  7782

Kairat Davletov is an academic researcher from Al-Farabi University. The author has contributed to research in topics: Population & Population health. The author has an hindex of 9, co-authored 11 publications receiving 2444 citations.

Papers
More filters
Journal ArticleDOI

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Theo Vos, +2419 more
- 17 Oct 2020 - 
TL;DR: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates, and there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries.
Journal ArticleDOI

Drinking to death: the changing face of liver disease

Max Griswold, +509 more
Journal ArticleDOI

Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016

Valery L. Feigin, +215 more
TL;DR: In 2016, the global lifetime risk of stroke from the age of 25 years onward was approximately 25% among both men and women, and there was geographic variation in the lifetime risk, with the highest risks in East Asia, Central Europe, and Eastern Europe.
Journal ArticleDOI

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019.

Rafael Lozano, +905 more
- 17 Oct 2020 - 
TL;DR: To assess current trajectories towards the GPW13 UHC billion target—1 billion more people benefiting from UHC by 2023—the authors estimated additional population equivalents with UHC effective coverage from 2018 to 2023, and quantified frontiers of U HC effective coverage performance on the basis of pooled health spending per capita.
Journal ArticleDOI

Repositioning of the global epicentre of non-optimal cholesterol

Cristina Taddei, +890 more
- 04 Jun 2020 - 
TL;DR: The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.